CX3CR1 and Parkinson disease: A study by Wang et al. further demonstrated that CX3CR1 expression is downregulated during the early stages of PD and gradually returns to baseline levels in the later stages in rAAV-hSYN-injected C57BL/6 mice, suggesting dynamic regulation of CX3CR1 during disease progression (Wang et al., 2020).